Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: The purpose of this study was to investigate the prognostic value of the pretreatment inflammatory markers platelet‐to‐lymphocyte ratio (PLR) and the neutrophil‐to‐lymphocyte ratio (NLR) in patients with head and neck squamous cell carcinoma (HNSCC). Methods: We conducted a retrospective analysis of patients diagnosed with HNSCC at McGill University Health Center from 2000 to 2011 (273 patients were retained). Hematologic parameters were recorded within 4 weeks of diagnosis. Mortality and recurrence rates were compared according to various PLR and NLR thresholds. Results: Of the total patients, 20.5% died and 11.0% had disease recurrence. PLR >170 was associated with higher mortality (p = .008). The subgroup with a combination of PLR >170 and NLR ≤3.0 was associated with higher T classification and highest mortality (43%). NLR above 4.2 predicted higher rates of recurrence (p < .0001). The NLR/PLR combination was at least as good as TNM staging in predicting survival. Conclusion: PLR is an independent predictor of mortality; NLR is an independent predictor of recurrence in HNSCC. These parameters might be used to identify advanced stages rapidly and economically. © 2014 Wiley Periodicals, Inc. Head Neck 37: 103–110, 2015
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399 · cited 7×
“anti-inflammatory medications decrease incidence and reduce mortality from certain types of cancers.(5) Also,”
BackgroundInfluentialInflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797 · cited 1×
“Neutrophils are not only known to produce angiogenic cytokines, such as vascular endothelial growth factor and interleukin (IL)-8,(25) but have also been shown to generate an abundant source of matrix metalloproteinase (MMP)-9 (gelanitase B) that was demonstrated to induce a switch into an angiogenic state in tumor ce…”
BackgroundGender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
Naugler, W. E., & Karin, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.007 · Cited by 730 · cited 2×
“IL-6 is a major cytokine of acute inflammation and its dysregulation has been associated with many inflammatory conditions.(30) In fact, IL-6 acts downstream of ras oncogene(31) and has been implicated in various malignancies, such as multiple myeloma(32) and hepatocellular carcinoma.”
BackgroundTumor-Associated Macrophages Press the Angiogenic Switch in Breast Cancer
Lin, E. Y., & Pollard, J. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0912 · Cited by 463 · cited 1×
“In breast carcinomas, tumor-associated macrophages release vascular endothelial growth factor, urokinase-type plasminogen activator, as well as MMP-9, which all contribute to angiogenesis in the tumor microenvironment.(28) Tumor-associated macrophages and other leukocytes have additionally been linked with inducing ex…”
BackgroundOncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Ancrile, B., Lim, K.-H., & Counter, C. M. (2007) · Genes & Development · doi:10.1101/gad.1549407 · Cited by 422
Cited by
Guo, J., Chen, S., Chen, Y., Li, S., & Xu, D. (2018) · Cancer Management and Research · doi:10.2147/cmar.s156071 · Cited by 54
Lin, C., Chen, S., Simard, S., Chang, J. T., & Lai, Y. (2018) · Psycho-Oncology · doi:10.1002/pon.4697 · Cited by 33
Lin, C.-R., Chen, S.-C., Chang, J. T.-C., Fang, Y.-Y., & Lai, Y.-H. (2016) · Journal of Nursing Research · doi:10.1097/jnr.0000000000000169 · Cited by 31
Metadata
- Authors
- Rassouli, A., Saliba, J., Castano, R., Hier, M., & Zeitouni, A. G.
- Venue
- Head & Neck
- Publisher
- Wiley
- Published
- 2014-04-15
- Volume
- 37
- Issue
- 1
- Pages
- 103-110
- ISSN
- 1043-3074 (ISSN-L)
- 1097-0347
- OpenAlex
- W1559164420
- Cited by
- 160
- References
- 7
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. https://app.cochat.ai/papers/10.1002/hed.23567
- The paper
- Rassouli, A., Saliba, J., Castano, R., Hier, M., & Zeitouni, A. G. (2015). Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head & Neck. https://doi.org/10.1002/hed.23567
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.